Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat

Neuroscience

Volumn 82, Issue 4, 1997, Pages 1131-1149

  Buckley, N E ^a   Hansson, S ^b   Harta, G ^a   Mezey, É ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain; Cannabinoid receptors; Embryogenesis; Liver; Uterus

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; DRUG RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; EMBRYO DEVELOPMENT; NEURAL TUBE; NONHUMAN; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; TISSUE DISTRIBUTION; ANIMAL; BIOSYNTHESIS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT; UTERUS;

ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; TISSUE DISTRIBUTION; UTERUS;

EID: 0031594480     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00348-5     Document Type: Article

References (53)

1. Adler M. W. and Geller E. B. (1986) Ocular effects of cannabinoids. In Cannabinoids as Therapeutic Agents (eds Mechoulam R.), pp. 51-67. CRC Press, Boca Raton, FL.
2. Billiar T. R. and Curran R. D. (eds) (1992) Hepatocyte and Kupffer Cell Interactions. CRC Press, Boca Raton, FL.
3. Bonnin A., de Miguel R., Castro J. G., Ramos J. A., Fernandez-Ruiz J. J. Effects of perinatal exposure to delta-9- tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. molec. Neurosci. 7:1996;291-308.
4. Bonnin A., de Miguel R., Hernandez M. L., Ramos J. A. and Fernandez-Ruiz J. J. (1995) The prenatal exposure to delta-9- tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 23/24, 2177-2184.
5. Bradley D. J., Towle H. C., Young W. S. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J. Neurosci. 12:1992;2288-2302.
6. Cadogan A. K., Boyd E. A., Alexander S. P. H., Kendall D. A. Influence of cannabinoids on dopamine release and cAMP generation in the rat striatum. Br. J. Pharmac. 119:1996;31P.
7. Chandler L. S., Richardson G. A., Gallagher J. D., Day N. L. Prenatal exposure to alcohol and marijuana: effects on motor development of preschool children. Alcoholism: clin. exp. Res. 20:1996;455-461.
8. Das S. K., Paria B. C., Chakraborty L., Dey S. K. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc. natn. Acad. Sci. U.S.A. 92:1995;4332-4336.
9. Day N. and Richardson G. (1991) Prenatal marijuana use: epidemiology, methodological issues and infant outcome. In Clinics in Perinatology (ed. Chasnoff I. J.), Vol. 18, pp. 77-92. W. B. Saunders, Philadelphia.
10. Day N. L., Richardson F. A., Goldschmidt L., Robles N. P. M. T., Stoffer D. S., Cornelius M. D., Geva D. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol. Teratol. 16:1994;169-175.
11. Feng T. Substance abuse in pregnancy. Curr. Opin. Obstet. Gynecol. 5:1993;16-23.
12. Fisher D. A., Dussault J. K., Sack J., Chopra I. J. Ontogenesis of hypothalamic-pituitary-thyroid function in man, sheep and rat. Rec. Prog. Horm. Res. 33:1977;59.
13. Fowden A. Endocrine regulation of fetal growth. Reprod. Fertil. Dev. 7:1995;351-363.
14. Fride E., Mechoulam R. Developmental aspects of anandamide - ontogeny of response and prenatal exposure. Psychoneuroendocrinology. 21:1996;157-172.
15. Fried P. A. The Ottawa prenatal prospective study (OPPS): methodological issues and findings - it's easy to throw the baby out with the bath water. Life Sci. 56:1995;2159-2168.
16. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
17. Garcia L., de Miguel R., Ramos J. A., Fernandez-Ruiz J. J. Perinatal delta-9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend. 42:1996;155-166.
18. Gerard C. M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134.
19. Hillard C. J., Farber N. E., Hagen T. C., Bloom A. S. The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmac. Biochem. Behav. 20:1984;547-550.
20. Hsu S., Raine L. Protein A, avidin, and biotin in immunohistochemistry. J. Histochem. Cytochem. 29:1981;1349-1353.
21. Hunyady B., Krempels K., Harta G., Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J. Histochem. Cytochem. 44:1996;1353-1362.
22. Kaminski N. E. Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. Biochem. Pharmac. 52:1996;1133-1140.
23. Keeney D. S., Jenkins C. M., Waterman M. R. Developmentally regulated expression of adrenal 17A-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology. 136:1995;4872-4879.
24. Mailleux P., Vanderhaeghen J. J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci. Lett. 148:1992;173-176.
25. Matsuda L., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
26. Matsuda L. A., Bonner T. I., Lolait S. J. Localization of cannabinoid receptor mRNA in rat brain. J. comp. Neurol. 327:1993;535-550.
27. Mechoulam R. and Feigenbaum J. J. (1987) Towards cannabinoid drugs. In Progress in Medicinal Chemistry (eds Ellis G. P. and West G. B.), pp. 159-200. Elsevier, Oxford.
28. Mellon S. H., Compagnone N., Sander M., Cover C., Ganten D., Djavidani B. Rodent models for studying steroids and hypertension: from fetal development to cells in culture. Steroids. 60:1995;59-64.
29. Muchtar S., Almog S., Torracca M. T., Saettone M. F., Benita S. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Ophthalm. Res. 24:1992;142-149.
30. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
31. Navarro M., Rubio P., Rodriguez de Fonseca F. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology. 122:1995;1-14.
32. Obregon M. J., Mallol J., Pastor R., Morreale de Escobar G., Escobar del Rey F. L-Thyroxine and 3,5,3′-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology. 114:1984;305-307.
33. Paria B. C., Das S. K., Dey S. K. The preimplanatation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. natn. Acad. Sci. U.S.A. 92:1995;9460-9464.
34. Paria B. C., Deutsch D. D., Dey S. K. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Molec. Reprod. Devl. 45:1996;183-192.
35. Paria B. C., Yang Z. M., Dey S. K. Cannabinoids arrest preimplantation mouse embryo development via brain-type cannabinoid receptors. Biol. Reprod. 54:1996;96.
36. Pate D. W., Jarvinen K., Urtti A., Jarho P., Fich M., Mahadevan V., Jarvinen T. Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sci. 58:1996;1849-1860.
37. Pate D. W., Jarvinen K., Urtti A., Jarho P., Jarvinen T. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr. Eye Res. 14:1995;791-797.
38. Paterson S. J., Pertwee R. G. Characterization of the cannabinoid binding site in the guinea-pig. Br. J. Pharmac. 109:1993;82P.
39. Pertwee R. G., Fernando S. R., Griffin G., Ryan W., Razdan R. K., Compton D. R., Martin B. R. Agonist-antagonist characterization of 6′-cyanohex-2′-yne-delta-8-tetrahydrocannabinol in two isolated tissue preparations. Eur. J. Pharmac. 315:1996;195-201.
40. Pertwee R. G., Fernando S. R., Nash J. E., Coutts A. A. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmac. 118:1996;2199-2205.
41. Pertwee R. G., Stevenson L. A., Elrick D. B., Mechoulam R., Corbett A. D. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmac. 105:1992;980-984.
42. Robins L. M., Mills J. L. Effects of in utero exposure to street drugs. Am. J. Public Health. 83:1993;9-31.
43. Rodriguez de Fonseca F., Hernandez M. L., De Miguel R., Fernandez-Ruiz J. J., Ramos J. A. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids. Pharmac. Biochem. Behav. 41:1992;469-474.
44. Rubio P., Rodriguez de Fonseca F., Munoz R. M., Ariznavarreta C., Martin-Calderon J. L., Navarro M. Long-term behavioral effects of perinatal exposure to a delta-9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci. 56:1995;2169-2176.
45. Schlicker E., Timm J., Gothert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch. Pharmac. 354:1996;791-795.
46. Schmid P. C., Paria B. C., Krebsbach R. J., Schmid H. H. O., Dey S. K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. natn. Acad. Sci. U.S.A. 94:1997;4188-4192.
47. Sugrue M. F. The pharmacology of antiglaucoma drugs. Pharmac. Ther. 43:1989;91-138.
48. Tsou K., Brown S., Mackie K., Walker J. M. The distribution of the CB1 receptor in rat brain as determined by a CB1 antibody. Neuroscience. 00:1997;000-000.
49. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N and P/Q-type calcium currents in cultured rat hippocampal neurons. J. Neurophysiol. 00:1997;000-000.
50. Voth E. A., Schwartz R. H. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana. Ann. intern. Med. 126:1997;791-798.
51. Weiss L. (1983) Cell and Tissue Biology, A Textbook of Histology. Urban & Schwarzenberg, Baltimore, MD.
52. Yang Z., Paria B., Dey S. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol. Reprod. 55:1996;756-761.
53. Zuckerman B., Frank D. A., Hingson R., Amaro H., Levenson S. M., Kayne H., Parker S., Vinci R., Aboagye K., Fried L. E., Cabral H., Timperi R. Effects of maternal marijuana and cocaine use on fetal growth. New Engl. J. Med. 320:1989;762-768.